|Bid||22.62 x 1000|
|Ask||23.25 x 900|
|Day's Range||22.76 - 22.95|
|52 Week Range||12.80 - 24.98|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 10, 2020 - Aug. 14, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||24.00|
Anaqua, the leading provider of innovation and intellectual property management solutions, and Clarivate Plc (CCC), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced a strategic partnership that brings together two of the leading service providers in the trademark industry. The partnership will see CompuMark™, a part of Clarivate and industry leader in trademark research and protection solutions, working with Anaqua to help IP professionals work more efficiently. The alliance will provide seamless integration between the ANAQUA® IP Management platform and the CompuMark trademark research and protection platform, delivering significant workflow efficiencies for IP professionals.
Clarivate Analytics Plc (CCC) delivered earnings and revenue surprises of -12.50% and -1.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Clarivate Analytics Plc (CCC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LONDON and PHILADELPHIA, April 22, 2020 /CNW/ -- Clarivate Analytics (NYSE:CCC - News) today announced the addition of open access data to the Journal Citation Reports profile pages to increase transparency around open access models in scholarly publishing. The Journal Citation Reports is an annual journal report from the Web of Science, the world's largest publisher-independent global citation database. This provides the research community with transparent, publisher-neutral information about the relative contribution of articles published free to read and re-use under Creative Commons licenses ('gold open access') to a journal's overall volume of content and citations.
LONDON and PHILADELPHIA, April 22, 2020 /CNW/ -- Clarivate Analytics Plc (NYSE:CCC - News), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, has today released a new report unveiling the bioplastics1 innovation landscape. Download the full report entitled 'From the Plastics Present to a Sustainable Future'. With growing consumer, governmental and organizational awareness of the need to radically change our approach to plastic usage and disposal, bioplastic has emerged as one of the potential solutions to a more sustainable future.
LONDON , March 9, 2020 /CNW/ -- The Centre for Innovation in Regulatory Science (CIRS), a neutral and independent, international member-based organisation headquartered in the UK, has been awarded a phase two grant of $1.09m by the Bill & Melinda Gates Foundation to continue their collaborative endeavours to expedite patient access to medicines in specific areas of greatest medical need in Low and Middle Income Countries (LMICs)*1. The grant has been awarded to CIRS for the purpose of 'Tracking Regulatory Performance Metrics in Low and Middle Income Countries' to accelerate and consolidate the activities around a unique metrics collection programme which aims to assist LMICs achieve targeted improvements in regulatory performance goals and ultimately, to accelerate registration of quality medicines in these countries.
LONDON and PHILADELPHIA, Feb. 19, 2020 /CNW/ -- The global innovation environment is rapidly fragmenting as large organizations2, share of global inventions drops to 18% in the face of competition from market disruptors. This is according to the Derwent Top 100 Global Innovators 2020 report, released today by Clarivate Analytics Plc (NYSE:CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation. The annual report, which can be downloaded here, identifies the world's most innovative organizations.
Cortellis identifies new drugs for treating indications for breast cancer, lymphoma, multiple sclerosis (MS) and migraine touted for commercial and clinical success PHILADELPHIA and LONDON , Feb. 10, 2020 ...
Helping organizations navigate complex global patent data throughout the innovation lifecycle LONDON and PHILADELPHIA , Feb. 4, 2020 /CNW/ -- Patent information is a powerful source of business intelligence ...
LONDON and PHILADELPHIA, Jan. 17, 2020 /CNW/ -- Clarivate Analytics plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced it has signed a definitive agreement to acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited ("PEL", NSE: PEL, BSE: 500302), part of global business conglomerate Piramal Group. The $950 million purchase price–approximately 12x trailing DRG Adjusted EBITDA, taking into account acquisition cost synergies but not revenue synergies–includes $900 million in cash and approximately $50 million in Clarivate ordinary shares to be issued following the one-year anniversary of closing.